Since 2022, Member of the Board of Directors, Non-Executive, Independent, Jamjoom Pharmaceuticals Factory Co. Since 2022, Chairman of the Audit committee at the company. Since 2021, Chief Executive Officer and Board Member at HSBC Saudi Arabia, a Saudi joint stock company engaging in financial services. From 2021 to 2022, Deputy CEO at HSBC Saudi Arabia, a Saudi joint stock company engaging in financial services. From 2019 to 2021, General Manager and Head of Banking at HSBC Saudi Arabia, a Saudi joint stock company engaging in financial services. From 2016 to 2019, Managing Director and Head of Investment Banking Advisory at HSBC Saudi Arabia, a Saudi joint stock company engaging in financial services. From 2006 to 2009, Associate, Equity Capital Markets, ABN AMRO Rothschild, London, UK.
| Company | Ticker | Role | Since | Sector |
|---|---|---|---|---|
| Jamjoom Pharmaceuticals Factory Co. | 4015 | Independent Director Independent | Jan 1, 2022 | Health Care |
| Category | Entries |
|---|---|
| Previous Employers | Jamjoom Pharmaceuticals Factory Co., HSBC Saudi Arabia, ABN AMRO Rothschild |
| Key Roles | Member of the Board of Directors, Chairman of the Audit Committee, Chief Executive Officer, Deputy CEO, General Manager, Head of Banking, Managing Director, Head of Investment Banking Advisory, Associate |
| Sectors | banking, healthcare, professional services |
| International Boards | ABN AMRO Rothschild |
| Education | Bachelor of Science in Accounting from the College of Business Administration at Prince Sultan University, the Kingdom, 2005. Master's degree in Business Administration from Jones Business School, Rice University, United States, 2011 |
| Universities | Prince Sultan University, Rice University |